{
    "clinical_study": {
        "@rank": "114428", 
        "arm_group": [
            {
                "arm_group_label": "Exercise", 
                "arm_group_type": "Experimental", 
                "description": "The exercise intervention group will receive social, behavioral support and research staff contact time to encourage them to increase their activity level to include twice weekly strength-training sessions and 150 min of walking/week (e.g., three 50-min walking sessions or five 30-min walking sessions) over 12 months."
            }, 
            {
                "arm_group_label": "Attention Control (Health Education)", 
                "arm_group_type": "Active Comparator", 
                "description": "The Attention Control Group will be provided written information that emphasizes the importance of a healthy lifestyle. Participants will be encouraged to follow the NCI and ACS physical activity guidelines. This procedure was followed in our exercise trials, with no increase in physical activity levels observed at follow-up among women in the usual care group.  Attention Control participants will also receive frequent contacts throughout the 12 month intervention. Each month, women randomized to attention control will be contacted by phone to discuss a health education topic of interest"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators propose to examine 121 postmenopausal women diagnosed with\n      hormone-receptor positive breast cancer who have been taking aromatase inhibitors (AI) for\n      at least 6 months and are experiencing at least mild arthralgia originating during AI\n      treatment, the yearlong effect of exercise vs. attention control (health education), and on\n      toxic side effects of AI."
        }, 
        "brief_title": "Hormones and Physical Exercise (HOPE) Study", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Breast Cancer", 
            "Arthralgia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Arthralgia", 
                "Breast Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "The investigators propose to examine, in 121 postmenopausal breast cancer survivors who have\n      been taking an AI for at least 2 months and are currently experiencing at least mild\n      arthralgia associated with AI use, the effect of a randomized controlled exercise\n      intervention vs. attention control (health education) on severity of arthralgia,\n      endocrine-related Quality of Life(QOL), Bone Mineral Density(BMD), and mediators/mechanisms\n      influencing the effect of exercise on arthralgia severity. Women will be randomized to a\n      year long exercise program or attention control group. Women randomized to exercise will\n      participate in 150 min/wk of aerobic exercise and a twice-weekly strength training program.\n      The investigators will conduct baseline, six-, and 12-month clinic visits, as well as a 3-\n      and 9-month mailing to evaluate the effect of the intervention on study outcomes."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Postmenopausal women (defined as the surgical or natural absence of menstrual cycles\n             for at least 1 year prior to breast cancer diagnosis).\n\n          -  75 years or younger\n\n          -  AJCC Stages I-IIIC Breast Cancer\n\n          -  Taking an AI for at least 2 months\n\n          -  Currently experiencing at least mild arthralgia (= or > 3 on the BPI) associated with\n             AI use\n\n          -  Physically able to exercise and physician consent to start an exercise program\n\n          -  Sedentary activity pattern (< 90 mins/week of moderate-to-vigorous intensity sports\n             activity) within the past year and low fitness level\n\n          -  No more than one strength training session per week within the past year\n\n          -  Agrees to be randomly assigned to either exercise or attention control\n\n          -  Gives informed consent to participate in all study activities\n\n          -  Able to come for baseline, 6-, and 12-month clinic visits and strength training\n             sessions (6-month intervention study - able to come for baseline, 6-month clinic\n             visits and strength training sessions).\n\n          -  Mentally competent\n\n        Exclusion Criteria:\n\n          -  Lymphedema with self reported 'flare up' in the past 4 months"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "121", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 4, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02056067", 
            "org_study_id": "HIC0906005263"
        }, 
        "intervention": [
            {
                "arm_group_label": "Exercise", 
                "description": "The exercise intervention group will receive social, behavioral support and research staff contact time to encourage them to increase their activity level to include twice weekly strength-training sessions and 150 min of walking/week (e.g., three 50-min walking sessions or five 30-min walking sessions) over 12 months.", 
                "intervention_name": "Exercise", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Attention Control (Health Education)", 
                "description": "The Attention Control Group will be provided written information that emphasizes the importance of a healthy lifestyle. Participants will be encouraged to follow the NCI and ACS physical activity guidelines. This procedure was followed in our exercise trials, with no increase in physical activity levels observed at follow-up among women in the usual care group. Attention Control participants will also receive frequent contacts throughout the 12 month intervention. Each month, women randomized to attention control will be contacted by phone to discuss a health education topic of interest", 
                "intervention_name": "Attention Control (Health Education)", 
                "intervention_type": "Behavioral"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Hormones"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 27, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "New Haven", 
                    "country": "United States", 
                    "state": "Connecticut"
                }, 
                "name": "Yale University"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Hormones and Physical Exercise (HOPE) Study", 
        "overall_official": {
            "affiliation": "Yale University", 
            "last_name": "Melinda Irwin, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Measured using the Brief Pain Inventory (BPI). Subjects are asked to rate pain by circling  a number from 0-10 that describes pain at its \"worst\", \"least\", and \"average\" with 0 being no pain and 10 being \"pain as bad as you can imagine\".", 
                "measure": "Change from Baseline in Arthralgia Severity", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Measured using the Brief Pain Inventory (BPI). Subjects are asked to rate pain by circling  a number from 0-10 that describes pain at its \"worst\", \"least\", and \"average\" with 0 being no pain and 10 being \"pain as bad as you can imagine\".", 
                "measure": "Change from Baseline in Arthralgia Severity", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02056067"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Yale University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yale University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2009", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}